M. S. Niederman

862 total citations
13 papers, 531 citations indexed

About

M. S. Niederman is a scholar working on Epidemiology, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. S. Niederman has authored 13 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Critical Care and Intensive Care Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. S. Niederman's work include Pneumonia and Respiratory Infections (9 papers), Nosocomial Infections in ICU (7 papers) and Respiratory viral infections research (4 papers). M. S. Niederman is often cited by papers focused on Pneumonia and Respiratory Infections (9 papers), Nosocomial Infections in ICU (7 papers) and Respiratory viral infections research (4 papers). M. S. Niederman collaborates with scholars based in United States, Spain and France. M. S. Niederman's co-authors include Antoní Torres, W. R. Summer, Paola Jubert, Patricia Aruj, Montserrat Rué, Jordi Rello, Antonio Artigas, Carlos M. Luna, Jordi Vallès and Fernando Ríos and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and European Respiratory Journal.

In The Last Decade

M. S. Niederman

12 papers receiving 506 citations

Peers

Countries citing papers authored by M. S. Niederman

Since Specialization

Citations

This map shows the geographic impact of M. S. Niederman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. S. Niederman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. S. Niederman more than expected).

Fields of papers citing papers by M. S. Niederman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. S. Niederman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. S. Niederman. The network helps show where M. S. Niederman may publish in the future.

Co-authorship network of co-authors of M. S. Niederman

This figure shows the co-authorship network connecting the top 25 collaborators of M. S. Niederman. A scholar is included among the top collaborators of M. S. Niederman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. S. Niederman. M. S. Niederman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Reply to Taccone et al, Wolff and Mourvillier, Masuta and Iwata, and Lahey 2012 ·Clinical Infectious Diseases ·Richard G. Wunderink, M. S. Niederman, Marin H. Kollef, Andrew F. Shorr, Jean Chastre	1
2	Telavancin for the treatment of hospital-acquired pneumonia in severely ill and older patients: the ATTAIN studies 2009 ·Critical Care ·Eric Rubinstein, G. Ralph Corey, (unknown), M. S. Niederman, Andrew F. Shorr, Antoni Torres, (unknown), H. David Friedland	8
3	Clinical Presentation and Diagnostic Workup for Community-Acquired Pneumonia: The Gulf Corporation Council CAP Working Group Consensus Statement 2007 ·Journal of Chemotherapy ·Ziad A. Memish, Yaseen M. Arabi, (unknown), Hamdan Al Jahdali, (unknown), M. S. Niederman, (unknown)	3
4	Rationale for Producing Evidence-Based Guidelines for Community-Acquired Pneumonia in the Gulf Corporation Council 2007 ·Journal of Chemotherapy ·Ziad A. Memish, (unknown), Yaseen M. Arabi, (unknown), M. S. Niederman, (unknown)	5
5	Decrease in intravenous antibiotic use with adjunctive aerosolized amikacin treatment in intubated mechanically ventilated patients with Gram-negative pneumonia 2007 ·Critical Care ·M. S. Niederman, Jean Chastre, K Corkery, Robert Fishman, James B. Fink, Charles‐Édouard Luyt, Miguel Sánchez	1
6	Appropriateness and delay to initiate therapy in ventilator-associated pneumonia 2005 ·European Respiratory Journal ·Carlos M. Luna, Patricia Aruj, M. S. Niederman, (unknown), Damian A. Violi, (unknown), Fernando Ríos, (unknown), Sebastián Gando	176
7	Infecciones respiratorias en UCI 1999 ·Dialnet (Universidad de la Rioja) ·(unknown), (unknown), M. S. Niederman	4
8	Strategies for prevention of community-acquired pneumonia. 1998 ·PubMed ·(unknown), M. S. Niederman	3
9	Evaluation of Outcome for Intubated Patients with Pneumonia Due to Pseudomonas aeruginosa 1996 ·Clinical Infectious Diseases ·Jordi Rello, Paola Jubert, Jordi Vallès, Antonio Artigas, Montserrat Rué, M. S. Niederman	121
10	Consensus on early intervention in community-acquired pneumonia: Panel discussion 1996 ·John G. Bartlett, Vincent T. Andriole, Peter S. Arno, Richard B. Brown, Jeff Etchason, (unknown), (unknown), (unknown), M. S. Niederman, (unknown), (unknown), Włodzimierz Stelmach, Alan D. Tice	1
11	New approaches to prevention and treatment of nosocomial pneumonia. 1995 ·PubMed ·(unknown), M. S. Niederman	11
12	Invasive Diagnostic Testing Is Not Needed Routinely to Manage Suspected Ventilator-Associated Pneumonia 1994 ·American Journal of Respiratory and Critical Care Medicine ·M. S. Niederman, Antoní Torres, W. R. Summer	173
13	Demonstration of a free elastolytic metalloenzyme in human lung lavage fluid and its relationship to alpha 1-antiprotease. 1984 ·PubMed ·M. S. Niederman, Linda Fritts, William W. Merrill, Robert B. Fick, Richard A. Matthay, Herbert Y. Reynolds, J. Bernard L. Gee	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact